Executive Summary
            
                Newlink Technology reported QQ2 2025 revenue of 133.74 million CNY, reflecting a robust YoY gain of 71.55% but accompanied by a widening quarterly loss. Gross profit stood at 24.07 million CNY, delivering a gross margin of 18.0%. Notwithstanding top-line strength, operating expenses surged to 71.50 million CNY, driving an EBITDA of -48.35 million CNY and an operating loss of -47.43 million CNY. Net income registered -64.38 million CNY with a negative net margin of -48.1% and an EPS of -0.0686. The earnings profile indicates a business in a high-investment phase, prioritizing R&D, sales/marketing, and administrative scaling to capture AI, big data, RPA, and healthcare IT opportunities in China. Strong liquidity and very light leverage provide a cushion for ongoing investment, but profitability and cash flow discipline will be critical to monitor over the next quarters.
Key takeaways for investors: (1) Revenue momentum is positive on a YoY basis but profitability is materially pressured by elevated operating costs; (2) The company maintains a solid liquidity position (current ratio 4.53, cash ratio 2.04) with minimal leverage (debt ratio 0.0277, debt/equity 0.0337), suggesting capacity to fund growth initiatives; (3) Margin recovery will depend on mix shift toward higher-margin offerings and continued efficiency gains in product development and delivery. Absent explicit forward guidance, an earnings cadence driven by cost discipline and a path to improving EBITDA will be pivotal to the stock's investment thesis.            
         
        
        
            Key Performance Indicators
            
                                    
                                    
                                    
                                    
                        
                        
                                                    
                                QoQ: 0.00% | YoY:-245.77%                            
                                             
                                    
                        
                        
                                                    
                                QoQ: 0.00% | YoY:-248.22%                            
                                             
                             
         
        
        
        
        
            Key Insights
            
                
                                    Revenue: 133,740,000 CNY; YoY +71.55%; QoQ +0.00%
Gross Profit: 24,066,000 CNY; YoY +240.30%; QoQ +0.00%
Gross Margin: 18.0%
Operating Income: -47,433,000 CNY; YoY -79.65%; QoQ +0.00%
EBITDA: -48,346,000 CNY; YoY -?%; QoQ +0.00%
EBITDA Margin: -36.15%
Net Income: -64,378,000 CNY; YoY -245.77%; QoQ +0.00%
Net Margin: -48.14%
EPS: -0.0686 CNY; YoY -248.22%; QoQ +0.00%
EPS Diluted: -0.0686 CNY; YoY -248.22%; QoQ +0.00%
Weighted Average Shares Outstanding: 937,880,597
Current Ratio: 4.53; Quick Rati...
                
             
         
    
    
    
        
        
            Financial Highlights
            
                Revenue: 133,740,000 CNY; YoY +71.55%; QoQ +0.00%
Gross Profit: 24,066,000 CNY; YoY +240.30%; QoQ +0.00%
Gross Margin: 18.0%
Operating Income: -47,433,000 CNY; YoY -79.65%; QoQ +0.00%
EBITDA: -48,346,000 CNY; YoY -?%; QoQ +0.00%
EBITDA Margin: -36.15%
Net Income: -64,378,000 CNY; YoY -245.77%; QoQ +0.00%
Net Margin: -48.14%
EPS: -0.0686 CNY; YoY -248.22%; QoQ +0.00%
EPS Diluted: -0.0686 CNY; YoY -248.22%; QoQ +0.00%
Weighted Average Shares Outstanding: 937,880,597
Current Ratio: 4.53; Quick Ratio: 4.53; Cash Ratio: 2.04
DaysSalesOutstanding: 208.40; DaysPayablesOutstanding: 66.80; Operating Cycle: 208.56; Cash Conversion Cycle: 141.75
Inventory Turnover: 571.22; Receivables Turnover: 0.432; Payables Turnover: 1.347
Debt Ratio: 0.0277; Debt/equity: 0.0337; Price to Book: 0.408; Price to Sales: 2.05; Price/Earnings: -1.063; Enterprise Value Multiple: -0.349
Cash per Share: 0.298; Price to Cash Flow Ratio: 0; Equity Multiplier: 1.217            
            
            Income Statement
            
                
                    
                    
                        | Metric | 
                        Value | 
                        YoY Change | 
                        QoQ Change | 
                    
                    
                    
                                                
                                | Revenue | 
                                133.74M | 
                                71.55% | 
                                0.00% | 
                            
                                                    
                                | Gross Profit | 
                                24.07M | 
                                240.30% | 
                                0.00% | 
                            
                                                    
                                | Operating Income | 
                                -47.43M | 
                                -79.65% | 
                                0.00% | 
                            
                                                    
                                | Net Income | 
                                -64.38M | 
                                -245.77% | 
                                0.00% | 
                            
                                                    
                                | EPS | 
                                -0.07 | 
                                -248.22% | 
                                0.00% | 
                            
                                            
                
             
         
        
        
            Key Financial Ratios
            
                                    
                    
                                    
                    
                                    
                    
                        
                            operatingProfitMargin                        
                        
                            -35.5%                        
                        
                                                    
                     
                                    
                    
                                    
                    
                                    
                    
                                    
                    
                                    
                    
                                    
                    
                             
         
        
        
    
    
    
        
            Management Commentary
            
                Note: No earnings call transcript data was provided in the accompanying materials. As a result, this section cannot cite management quotes or call-specific guidance. If a transcript becomes available, a themes-and-quotes synthesis will be provided, grouped by strategy, operations, and market conditions with context and implications.            
            
            
         
        
        
            Forward Guidance
            
                No explicit forward guidance was included in the provided materials for QQ2 2025. Given the ongoing high investment phase, near-term targets likely hinge on: (i) achieving operating leverage through revenue mix shifts toward higher-margin software and AI/big data solutions; (ii) scaling RPA, clinical IT platforms, and healthcare analytics with banks, hospitals, and asset management clients; (iii) maintaining disciplined cash burn while funding product development. Investors should monitor: revenue mix by segment (Financial Institutions, Medical Institutions, Other), R&D intensity relative to growth, customer concentration risk in China, regulatory developments affecting tech/AI providers, and the trajectory toward EBITDA profitability over the next few quarters.